Sunday, September 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 12, 2026

S&P 500 Update This Week: 4 Signals to Watch After Delta's Earnings

View original at nasdaq.com
S&P 500 Update This Week: 4 Signals to Watch After Delta's Earnings Key Points Delta Air Lines proved that strong operators can deliver under direct cost pressure, but most companies aren’t built to absorb shocks like fuel cost surges…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Colgate-Palmolive downgraded from Buy to Hold with price target cut from $96 to $85 due to oil-based input costs surging 33.9% in a single month and tallow prices up 40% year over year

    60% confidence
  • Identified 10 best stocks for investors to buy now, and Delta Air Lines was not one of them

    60% confidence
  • Procter & Gamble guided for 0% to 4% organic sales growth for the remainder of the year

    60% confidence
  • Upward pressure on oil prices could linger, and any renewed conflict could send prices toward the $120 to $130 range

    60% confidence

Data points we hold from this source

Procter & Gamble · ytd return2 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
S&P 500 Update This Week: 4 Signals to Watch After Delta's Earnings — Source | Via News | Via News